LEXARIA BIOSCIENCE CORP (LEXX) Stock Analyst Ratings
USA - NASDAQ:LEXX - US52886N4060 - Common Stock
1.02 USD
+0.04 (+3.71%)
0.99 USD
-0.03 (-2.94%)
ChartMill assigns a Buy % Consensus number of 83% to LEXX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 5.44. This target is 433.33% above the current price.
LEXX was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about LEXX.
In the previous month the buy percentage consensus was at a similar level.
LEXX was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-07-29 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-07-01 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-24 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-25 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-10 | HC Wainwright & Co. | Initiate | Buy |
| 2024-03-05 | Maxim Group | Maintains | Buy -> Buy |
| 2023-07-21 | Maxim Group | Initiate | Buy |
LEXARIA BIOSCIENCE CORP / LEXX FAQ
Can you provide the average price target for LEXARIA BIOSCIENCE CORP stock?
8 analysts have analysed LEXX and the average price target is 5.44 USD. This implies a price increase of 433.33% is expected in the next year compared to the current price of 1.02.
How do analysts rate LEXARIA BIOSCIENCE CORP (LEXX)?
The consensus rating for LEXARIA BIOSCIENCE CORP (LEXX) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.